New toxin receives national approval in the UK
Aesthetic manufacturer Croma-Pharma has announced the national approval of its new botulinum toxin in the UK.
Aesthetic manufacturer Croma-Pharma has announced the national approval of its new botulinum toxin in the UK.
As of January 25, aesthetic manufacturer Croma-Pharma has confirmed completion of the decentralised procedure for its new botulinum toxin.
Aesthetic manufacturer Croma-Pharma has expanded its face mask range.
Aesthetic manufacturer Croma-Pharma has launched a new polynucleotide based injectable named juvenus.
Aesthetics manufacturer Croma-Pharma has entered a licensing agreement with dermatology company Crescita Therapeutics for the rights to Pliaglis.
Aesthetics manufacturer Croma-Pharma has launched new skincare brand ‘Croma farewell’.